Sally Beauty Holdings, Inc. has been upgraded to a Buy rating following a share price drop to $13, presenting an attractive buying opportunity. The company reported strong Q2 results, with revenue increasing 2.3% to $903.4 million and comparable store sales rising 1.3%. Gross margins expanded notably to 52.7%, and the balance sheet remains strong with $157 million in cash, no revolver borrowings, and net debt leverage reduced to 1.5x. The company also continues share buybacks and projects fiscal year 2026 earnings per share of $2.06, an 8.4% year-over-year growth, with shares trading at a low forward P/E of 6.4x, signaling potential value for investors.
A regional nonprofit health plan reduced its Transparency in Coverage machine-readable file (MRF) production time from 45 days to less than 24 hours by integrating TALON's platform directly with its claims administration system. This eliminated a com...
ASUS has introduced two new Chromebooks in the US market: the budget-friendly CM15 laptop and the versatile CM32 Detachable 2-in-1 device. Both run on the MediaTek Kompanio 540 processor, offer up to 12 hours of battery life, and feature military-gra...
Slate Medicines, a biotech firm focused on migraine treatments, has appointed Mark W. Hahn to its Board of Directors. Hahn brings over 25 years of experience in life sciences, including leading companies through financial milestones and FDA approvals...
The global clinical trials market is projected to grow from $135.51 billion in 2026 to $176.32 billion by 2030, at a CAGR of 6.8%. Growth is fueled by advances in AI-enabled trial design, decentralized and hybrid trial platforms, and increasing deman...
California American Water and Sonoma County Fire District completed projects reducing wildfire risk around water facilities in Sonoma County. The efforts included clearing flammable vegetation near critical infrastructure like water storage tanks and...
